| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Immunodominant antigenic regions in a structural protein of the hepatitis E virus.
|
Virology
|
1994
|
1.22
|
|
2
|
IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein.
|
J Med Virol
|
1996
|
1.12
|
|
3
|
Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus.
|
J Clin Microbiol
|
1999
|
1.08
|
|
4
|
Experimental hepatic porphyria induced by polychlorinated biphenyls.
|
Toxicol Appl Pharmacol
|
1974
|
1.02
|
|
5
|
Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli.
|
Vaccine
|
2000
|
0.94
|
|
6
|
Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides.
|
Virology
|
1995
|
0.91
|
|
7
|
Antigenic diversity in the circumsporozoite protein of Plasmodium falciparum abrogates cytotoxic-T-cell recognition.
|
Infect Immun
|
1994
|
0.89
|
|
8
|
Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.
|
Vaccine
|
1997
|
0.86
|
|
9
|
Hemoglobin Raleigh (beta1 valine replaced by acetylalanine). Structural and functional characterization.
|
Biochemistry
|
1977
|
0.86
|
|
10
|
Hemoglobin Providence. A human hemoglobin variant occurring in two forms in vivo.
|
J Biol Chem
|
1976
|
0.85
|
|
11
|
Artificial NS4 mosaic antigen of hepatitis C virus.
|
J Med Virol
|
1999
|
0.84
|
|
12
|
Comparative characterization of antigenic epitopes in the immunodominant region of the protein encoded by open reading frame 3 in Burmese and Mexican strains of hepatitis E virus.
|
J Gen Virol
|
1994
|
0.83
|
|
13
|
Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii.
|
Vaccine
|
1997
|
0.83
|
|
14
|
Monopalmitic acid-peptide conjugates induce cytotoxic T cell responses against malarial epitopes: importance of spacer amino acids.
|
J Immunol Methods
|
1995
|
0.83
|
|
15
|
Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides.
|
Virology
|
1999
|
0.83
|
|
16
|
Artificial mosaic protein containing antigenic epitopes of hepatitis E virus.
|
J Virol
|
1994
|
0.82
|
|
17
|
Antigenic epitopes of the hepatitis A virus polyprotein.
|
Virology
|
1999
|
0.82
|
|
18
|
Hemoglobin Tarrant: alpha126(H9) Asp leads to Asn. A new hemoglobin variant in the alpha1beta1 contact region showing high oxygen affinity and reduced cooperativity.
|
Biochim Biophys Acta
|
1977
|
0.82
|
|
19
|
Hemoglobin Presbyterian: beta108 (G10) asparagine leads to lysine, A hemoglobin variant with low oxygen affinity.
|
FEBS Lett
|
1978
|
0.82
|
|
20
|
Hemoglobin Bethesda, beta 145 (HC2) Tyr replaced by His, in a Canadian family.
|
Am J Clin Pathol
|
1976
|
0.82
|
|
21
|
Hemoglobin S Travis: a sickling hemoglobin with two amino acid substitutions [beta6(A3)glutamic acid leads to valine and beta142 (h20) alanine leads to valine).
|
Eur J Biochem
|
1977
|
0.80
|
|
22
|
Identification of new cytotoxic T-cell epitopes on the 38-kilodalton lipoglycoprotein of Mycobacterium tuberculosis by using lipopeptides.
|
Infect Immun
|
1998
|
0.80
|
|
23
|
Rapid onset of malaria-induced mortality by immunizations with lipo-peptides: an experimental model to study deleterious immune responses and immunopathology in malaria.
|
Vaccine
|
1997
|
0.80
|
|
24
|
Hemoglobins Austin and Waco: two hemoglobins with substitutions in the alpha 1 beta 2 contact region.
|
Arch Biochem Biophys
|
1977
|
0.79
|
|
25
|
Hemoglobin Jackson, alpha 127 (H10) Lys replaced by Asn.
|
Am J Clin Pathol
|
1976
|
0.78
|
|
26
|
Protective immunity induced in squirrel monkeys with a multiple antigen construct against the circumsporozoite protein of Plasmodium vivax.
|
Am J Trop Med Hyg
|
1997
|
0.78
|
|
27
|
Hemoglobin Rio Grande [beta 8 (A5) Lys leads to Thr] a new variant found in a Mexican-American family.
|
Hemoglobin
|
1983
|
0.77
|
|
28
|
Hemoglobin connecticut (beta 21 (B3) Asp leads to Gly): a hemoglobin variant with low oxygen affinity.
|
Am J Hematol
|
1981
|
0.77
|
|
29
|
Hemoglobin Evanston: alpha 14(A12) Trp leads to Arg. A variant hemoglobin associated with alpha-thalassemia-2.
|
Biochim Biophys Acta
|
1983
|
0.76
|
|
30
|
Hemoglobin Brockton [beta 138 (H16) Ala----Pro]: an unstable variant near the C-terminus of the beta-subunits with normal oxygen-binding properties.
|
Biochemistry
|
1988
|
0.76
|
|
31
|
Hemoglobin Queens: alpha 34 (B15) Leu-Arg structural and functional properties and its association with Hb E.
|
Am J Hematol
|
1982
|
0.76
|
|
32
|
A case of hemoglobin Indianapolis [beta 112(G14) Cys----Arg] in an individual from Cordoba, Spain.
|
Hemoglobin
|
1986
|
0.76
|
|
33
|
Hemoglobin J Rovigo (alpha53 Ala replaced by Asp) in association with beta-thalassemia.
|
Hemoglobin
|
1978
|
0.75
|
|
34
|
Hemoglobin Cubujuqui (alpha 141 Arg-Ser): functional consequences of the alteration of the C-terminus of the alpha chain of hemoglobin.
|
Hemoglobin
|
1981
|
0.75
|
|
35
|
Hemoglobin Swan River [alpha 6(A4)Asp----Gly].
|
Hemoglobin
|
1987
|
0.75
|
|
36
|
Hb Hinsdale [beta 139 (H17)Asn----Lys]: a variant in the central cavity showing reduced affinity for oxygen and 2,3-diphosphoglycerate.
|
Hemoglobin
|
1989
|
0.75
|
|
37
|
Structural, functional, and subunit assembly properties of hemoglobin Attleboro [alpha 138 (H21) Ser----Pro], a variant possessing a site maturation at a critical C-terminal residue.
|
Biochemistry
|
1990
|
0.75
|
|
38
|
Hb Catonsville (glutamic acid inserted between Pro-37(C2)alpha and Thr-38(C3)alpha). Nonallelic gene conversion in the globin system?
|
J Biol Chem
|
1989
|
0.75
|
|
39
|
Hb Luxembourg [alpha 24(B5)Tyr----His], Hb Maputo [beta 47(CD6)Asp----Tyr], and Hb Fukuyama [beta 77(EF1)His----Tyr].
|
Hemoglobin
|
1991
|
0.75
|
|
40
|
Hb Rancho Mirage [beta 143(H21)His----Asp]; a variant in the 2,3-DPG binding site showing normal oxygen affinity at physiological pH.
|
Hemoglobin
|
1992
|
0.75
|
|
41
|
Hemoglobin Deaconess a new deletion mutant: beta131 (H9) glutamine deleted.
|
Biochem Biophys Res Commun
|
1975
|
0.75
|
|
42
|
Separation of hemoglobin variants by ion-exchange chromatography on Monobead resins.
|
J Chromatogr
|
1985
|
0.75
|
|
43
|
Hemoglobin Fannin-Lubbock [alpha2 beta 2 119 (GH2) Gly replaced by Asp]. A new hemoglobin variant at the alpha1 beta 1 contact.
|
Biochim Biophys Acta
|
1976
|
0.75
|
|
44
|
Hemoglobin Shelby [beta 131(H9) Gln----Lys] a correction to the structure of hemoglobin Deaconess and hemoglobin Leslie.
|
Hemoglobin
|
1984
|
0.75
|
|
45
|
Detection of atypical cholinesterase by an automated pH stat method. Report of a family with both atypical and silent gene alleles.
|
Clin Chem
|
1970
|
0.75
|
|
46
|
Characterization of Hb Volga [beta 27(B9)Ala-->Asp] and Hb J-Wenchang-Wuming [alpha 11(A9)Lys-->Gln] in the population of the United States.
|
Hemoglobin
|
1993
|
0.75
|
|
47
|
Circular dichroism of aggregated deoxyhemoglobin S and the effect of amino acids.
|
Arch Biochem Biophys
|
1976
|
0.75
|
|
48
|
Artificial mosaic proteins as new immunodiagnostic reagents: the hepatitis E virus experience.
|
Clin Diagn Virol
|
1996
|
0.75
|
|
49
|
Hemoglobin variants and methods used for their characterization during 7 years of screening at the Center for Disease Control.
|
Hemoglobin
|
1980
|
0.75
|
|
50
|
Structural and functional studies of hemoglobin Wayne: an elongated alpha-chain variant.
|
J Mol Biol
|
1984
|
0.75
|
|
51
|
The cyanogen bromide and maleyl peptides of the alpha and beta chains of human hemoglobin.
|
Hemoglobin
|
1977
|
0.75
|
|
52
|
Hemoglobin New Mexico: beta 100 (G2) Pro----Arg. A variant hemoglobin associated with erythrocytosis.
|
Biochim Biophys Acta
|
1985
|
0.75
|
|
53
|
Hb St. Francis [beta 121(GH4)Glu----Gly]: a new mutation at the same site as Hb D-Los Angeles.
|
Hemoglobin
|
1991
|
0.75
|
|
54
|
Hb Jacksonville [alpha 2 beta 2(54)(D5)Val----Asp]: a new unstable variant found in a patient with hemolytic anemia.
|
Hemoglobin
|
1990
|
0.75
|
|
55
|
Hemoglobin Twin Peaks alpha 113 (GH1) Leu----His.
|
Hemoglobin
|
1985
|
0.75
|
|
56
|
Hemoglobin Savaria--alpha 49(CE7)Ser----Arg in the United States.
|
Hemoglobin
|
1985
|
0.75
|
|
57
|
Hemoglobin Cheverly: an unstable hemoglobin associated with chronic mild anemia.
|
Pediatr Res
|
1983
|
0.75
|
|
58
|
Hemoglobin Dunn: alpha 6 (A4) aspartic acid replaced by asparagine.
|
Hemoglobin
|
1979
|
0.75
|
|
59
|
Erythrocytosis secondary to HB Bunbury [alpha 2 beta (2)94(FG1)Asp----Asn].
|
Hemoglobin
|
1992
|
0.75
|
|
60
|
Hemoglobin Tampa:beta 79 (EF3) aspartic acid replaced by tyrosine.
|
Biochim Biophys Acta
|
1980
|
0.75
|